Aspirin has long been recommended for secondary prevention of cardiovascular disease (CVD), but a new global study highlights considerable underuse for that purpose, especially in lower-income ...
BARCELONA, Spain—(UPDATED) Aspirin has long been the antiplatelet of choice for long-term secondary prevention in patients with coronary disease, but a meta-analysis of several trials suggests P2Y12 ...
Aspirin continues to be underused as a means of secondary prevention, particularly in countries with low per capita incomes but also in wealthier nations, a new analysis shows. The study combined data ...
Coronary heart disease, stroke, and chronic obstructive pulmonary disease are the top three causes of death worldwide, accounting for an estimated 1 and 3 deaths, per the World Health Organization ...
In noncardioembolic cerebrovascular disease (CVD), the use of antiplatelet agents rather than anticoagulants is recommended to reduce the risk of recurrent stroke and other cardiovascular events ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback